<DOC>
	<DOC>NCT01448759</DOC>
	<brief_summary>The purpose of this study is to evaluate plasma alcohol concentration in patients receiving Paclitaxel or Docetaxel infusion.</brief_summary>
	<brief_title>Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel</brief_title>
	<detailed_description>In this study, there is no experimental treatment, or experimental care.</detailed_description>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Chemotherapy with docetaxel or paclitaxel on an every 3week schedule. Patient with bitherapy are eligible only if the taxane is the first infusion. All type of tumor. Age&gt;18 years old. Signed written informed consent. Patient under 18. Patient with bitherapy, if docetaxel or paclitaxel is not administered first. Patient deprived of liberty.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Patients receiving docetaxel or paclitaxel. All tumors.</keyword>
</DOC>